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Abstract: Background: Herpes simplex virus
(HSV) is the primary herpesvirus implicated to
have a causal role in erythema multiforme
(EM), both in cases with an antecedent
herpetic infection and in idiopathic EM.
However, the association of EM with several
other viral infections has been clearly
documented.
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Objective: The aim of the present study was
to investigate a hypothetical role for the
remaining members of the herpesvirus family
in HSV-negative cases of EM.
Methods: Fresh, unfixed lesional skin biopsies
from 25 patients with HSV-negative EM were
studied for the presence of Epstein-Barr virus

Introduction
Erythema multiforme (EM) is a self-limited, acute or
recurrent polymorphous eruption composed of macules,
papules, bullae and targetoid lesions that are
symmetrically distributed but have a propensity for the
distal extremities and oral mucosa (1-5). Drugs,
mycoplasma and HSV infections are among the most
frequently implicated causes of EM (2,3).
Infection with herpes simplex virus (HSV) is the
dominant precipitating factor in the development of EM
in both children and adults (1-7). Recurrent EM is
preceeded by clinical lesions of recurrent HSV infection in
up to 80% of patients (5,7). Both HSV-I and HSV-II have
been shown to trigger EM (6). Despite this wellestablished clinical association, not all EM episodes are
preceeded by HSV infection and not all HSV episodes are
followed by EM (3,6). HSV has only rarely been cultured
from EM lesions (1,5,6,8). Although polymerase chain
reaction (PCR) and in situ hybridization (ISH) can reveal
the
presence
of
HSV
DNA
(1,4-8)
and
immunofluorescence
and
immunohistochemical
techniques can demonstrate HSV-specific antigens in the

(EBV), cytomegalovirus (CMV), human
herpesvirus-6
(HHV-6)
and
human
herpesvirus-7 (HHV-7) by using polymerase
chain reaction (PCR) and nested PCR.

Results: PCR revealed the absence of specific
DNA sequences for EBV, CMV, HHV-6 and
HHV-7 in all lesional EM specimens analyzed.
Conclusion: These findings do not support an
etiological role for non-HSV members of the
herpesvirus family in HSV-negative EM.
Key Words: Erythema multiforme, EpsteinBarr virus, cytomegalovirus, human
herpesvirus-6,
human
herpesvirus-7,
polymerase chain reaction.

lesional epidermis (6-8), there are cases in which no link
with HSV can be demonstrated. In addition, there are
documented case reports of EM in association with
herpes zoster virus, Coxsackie virus, hepatitis A, B and C
viruses, adenovirus, polio virus, orf, milker’s nodules and
HIV infection (7,9-11).
The herpesviruses are large DNA viruses with
intranuclear replication (12). Their ability to directly
infect lymphocytes and to establish latency in host tissues
have made them the focus of investigations in
dermatology (12-14).
The purpose of the present study was to elucidate a
potential etiopathogenetic role for other members of the
herpesvirus family in HSV-negative cases of EM.

Materials and Methods
Selection of Samples
This study involved 25 of 42 biopsy samples obtained
from patients with EM diagnosed in the Dermatology
Department of the Faculty of Medicine K›r›kkale
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University at between July 1998 and July 2002. In a
previous study performed by our department, these 25
samples were shown to be HSV-negative by PCR. In brief,
the diagnosis of EM was based on typical clinical features
and histology. Two punch biopsies were obtained from
each patient; one was fixed in formalin, embedded in
paraffin and routinely processed for histopathologic
examination and the other was quick-frozen in liquid
nitrogen and kept in a refrigerator at – 70 °C until PCR
analysis.
DNA extraction
DNA extraction and PCR procedures were performed
in the PCR laboratory of the Department of Microbiology
and Clinical Microbiology of the School of Medicine at
Gulhane Military Medical Academy. A standard protocol
for the extraction of DNA was used (15). In brief, skin
specimens were minced and pretreated by gentle mixing
with 50 µl of proteinase K (100 µg/ml, Sigma) and 200
µl of buffer (0.01 M of Tris-HCl [pH: 7.8] [10 mmol TrisHCl], 0.005 M of EDTA [20 mmol EDTA], 0.5% SDS),
and subsequent incubation at 40 °C overnight. Then
protein content was extracted twice with 1 volume of
alkali-phenol-chloroform-isoamyl alcohol (25:24:1).
Finally, total DNA was precipitated by the addition of 1
volume of 2-propanol. Extracted nucleic acids were
dissolved in 50 µl of TE buffer (pH 8.0).
PCR assay

HHV-6 and HHV-7: A nested PCR was performed for
HHV-6 and HHV-7 as described previously (16). The
HHV-6
sequences
of
outer
primers
were
5’ccgcaatcgaatccacctagcgg
3’
and
5’
gtgagaacggattcgaacagtgctg 3’. Inner primers were
5’cccatttacgatttcctgcaccacctc
3’
and
5’
ttcagggaccgttatgtcattgagcat 3’. The HHV-7 sequences of
outer primers were 5 agttccagcactgcaatcg 3’ and 5’
cacaaaagctcgctatcaa 3’. Inner primers were 5’
cgcatacaccaaccctactg 3’ and 5’ gactcattatggggatcgac 3’.
Amplification reactions were performed in a final volume
of 50 µl containing 10 mM of Tris-HCl (pH: 8.3), 50 mM
of potassium chloride, 2.0 mM of magnesium chloride,
0.1% Triton X-100, 2.5 U of Taq polymerase
(Boehringer Mannheim, Germany), 10 mM of
deoxynucleoside triphosphates, 30 pmol of each outer
primer and 10 µl of target DNA. The thermo was
programmed first to preheat at 95 °C for 5 min to
denaturate the samples and then the first round PCR
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reaction for HHV-6 was subjected to 30 cycles of
denaturation at 94 °C for 30 s, annealing at 55 °C for 30
s, extension at 72 °C for 30 s and final extension at 72
°C for 5 min in a DNA thermal cycler (MJ Research,
Watertown, Massachusetts, USA). The HHV-7 DNA
thermal condition included initial denaturation at 94 °C
for 10 min, denaturation at 94 °C for 30 s, annealing at
60 °C for 30 s, and extension at 72 °C for 30 s for 30
cycles and final extension at 72 °C for 5 min. The second
round of PCR was performed as follows: 5 µl of the
reaction mixture was transferred to the second round
reaction mixture containing 30 pmol of each inner primer
and the same buffer as in the first round. The
temperature cycle of second round PCR was also the
same. Multiple positive and negative controls were run in
each nested PCR assay.
Fifteen microliters of the amplification products were
analyzed by electrophoresis in an ethidium bromide
stained 2% agarose gel and photographed under UV light
by using Gel Doc 2000 (Bio-rad Laboratories-Segrate,
Milan, Italy) (a 100 bp DNA ladder was used as a size
marker to estimate the length of the products, BioLabs
Inc.). The expected size of the nested PCR product for
HHV-6 was 186 base pairs (bp) and the expected size of
nested PCR product for HHV-7 was 264 bp.

CMV and EBV: The following primer pair was selected
for CMV: 5’ ttgcaggccacgaacaacgt 3’ and 5’
gtctacggattgctgacgct 3’ (17). The sequence of the
primers used was 5’ ggc tgg tgt cac ctg tgt ta 3’ and 5’
cct tag gag gaa caa gtc cc 3’ for EBV (18). The first round
PCR procedures for CMV and EBV were performed as
described above. The PCR mixture was subjected to initial
denaturation at 94 °C for 5 min. Forty cycles of
amplification were performed in a DNA thermal cycler.
Each cycle consisted of a 1.5 min denaturation step at 94
°C, a 1 min annealing step at 60 °C, a 2 min extension
step at 72 °C and a 5 min final extension step at 72 °C.
Multiple positive and negative controls were run in each
nested PCR assay.
Fifteen µl of the amplification products were analyzed
by electrophoresis in an ethidium bromide stained 2%
agarose gel and photographed under UV light by using
Gel Doc 2000 (Bio-rad Laboratories-Segrate, Milan, Italy)
(a 100 bp DNA ladder was used as a size marker to
estimate the length of the products, BioLabs Inc.). The
expected size of the PCR product for CMV was 305 bp
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and the expected size of the nested PCR product for EBV
was 239 bp.
To prevent contamination, pre-PCR and post-PCR
steps were carried out in separate rooms. To detect
carry-over contamination, negative controls were
included in all reaction series: one negative sample was
processed for every four to five tested specimens, and
positive controls were included in each run. All PCR
results were confirmed by repeating the entire PCR
procedure.

Results
A total of 25 HSV-negative biopsy samples from 25
patients with EM were studied by PCR for the presence
of CMV, EBV, HHV-6 and HHV-7 DNA sequences. The
samples belonged to two males and 23 females. The age
range was 29-53 years (mean: 40.08; median: 46.00).
The disorder was recurrent in seven of 25 patients
(28%). The patients neither had clinical/laboratory data
of immunodefficiency, nor were they receiving
immunosuppressive therapy.

Figure:

By using the PCR, no positive signals for EBV, CMV,
HHV-6 and HHV-7 were detected in any of the patient
specimens (Figure).

Discussion
EM is thought to represent an immunologically
mediated attack by cytotoxic T lymphoctes and/or NK
cells and monocytes directed against keratinocytes
expressing non-self, particularly viral antigens (3,4,7).
HSV is the predominant virus in the herpesvirus family
that has been linked to EM. By PCR, HSV DNA has been
detected in one-third to two-thirds of specimens
examined in several studies (5,8). The present study was
based on the assumption that cases of EM that are HSVnegative might be provoked by infection with non-HSV
members of the herpesvirus family.
CMV is an ubiquitous β-herpesvirus that can induce
primary, latent, persistent and recurrent infections both
in immunocompetent and immunodeficient individuals
(12,19,20). Depending on the socioeconomic situation,
anywhere from 40 to 100% of adults in a community can

PCR amplification of CMV, EBV, HHV-6 and HHV-7 in lesional EM samples. SM: molecular DNA
weight marker; lane 1: negative patient sample; lanes 2,3,4,5: positive control samples for HHV-6,
EBV, HHV-7 and CMV respectively.
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be infected with CMV (12,21). Ulceration of the
perineum is the most common cutaneous finding of CMV
infection (20). In the field of dermatology, CMV has been
implicated in the etiopathogenesis of psoriasis, alopecia
areata, vitiligo and SLE (20-22). Seishima et al. (23)
suggested that CMV infection may lead to EM. The
present study is the first study evaluating CMV-EM
association that has failed to provide a supportive
evidence of a role for CMV infection in EM.
EBV is an ubiquitous γ-herpesvirus that infects both
adolescents and adults (12,24). The primary infection is
infectious mononucleosis, followed by lifelong carriage of
the virus in host tissues (4,24-26). EBV has been linked
to several epithelial malignancies, lymphoproliferative
disorders and lymphomas (24,25). EM has rarely been
reported in EBV-associated disorders, including chronic
fatigue syndrome (27). Chen et al. (4) investigated EM
specimens by PCR and detected EBV-specific DNA
sequences in two of 32 samples. However, the authors
identified no EBER (EBV-encoded RNA) signal by ISH in
the biopsy samples of any patient. The results of the
present study are in accordance with those of Chen et al.
and implicate that EBV does not play a major contributory
role in the etiopathogenesis of EM.
HHV-6 is a β-herpesvirus similar to CMV (12). It was
originally isolated in 1986 from peripheral blood
leukocytes of patients with HIV infection and
lymphoproliferative disorders (28). Primary infection is
exanthem subitum (roseola infantum), following which
the virus remains latent (12,29). HHV-6 is an ubiquitous
virus and by the age of 1 year, 75% of infants have
antibodies to HHV-6 (12). HHV-6 has been associated
with lymphoproliferative disorders and lymphomas (13).
Finally, HHV-7 is a β-herpesvirus first isolated from
human CD4 (+) T lymphocytes in 1990 (30). HHV-7 is
distinct from but related to HHV-6 (12). The virus has
been isolated from the peripheral blood of healthy people
and has been reported in association with chronic fatigue

syndrome, exanthem subitum-like illness and pityriasis
rosea (12,16,29,31). The infection is very ubiquitous,
and children are infected at an age similar to HHV-6
(12,29). Following primary infection the virus remains
latent (29). To our knowledge, the association of HHV-6
or HHV-7 with EM has not been documented. The
present study refutes a role for these viruses in EM.
The ability to amplify DNA and the sensitivity of PCR
facilitates the detection of subpicogram amounts of
pathogenic DNA sequences within host tissues (1,8,32).
This exquisite sensitivity can lead to false-positive results,
which represents a potential limitation of the diagnostic
efficacy of the procedure (8). PCR can also give falsenegative results due to inadequate sampling, lack of
positive control specimens or presence of PCR inhibitors
within the environment (33). In our study the risk of
false- negative results has been decreased by the use of
two sets of primers. In addition, positive control samples
interspersed within the patient samples constantly gave
positive signals for each virus and PCR procedures were
repeated twice with reproducible results.
Herpesviruses are ubiquitous viruses with infection
prevalences greater than that of EM prevalence. Given the
absolute lack of PCR-positive cases in lesional EM
specimens, we conclude that, except for HSV, the
remaining herpesvirus family members can be excluded
from the list of potential etiological factors in EM.
Nevertheless, the role of other DNA or RNA viruses as
initiators of HSV-negative EM is worth investigating and
further studies are awaited.
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